Approval of patent

A new formulation patent for oxytocin was approved by the Swedish patent authorities in February 2013.

PEPTONIC has received a patent on the new formulation of Vagitocin. Sweden was the first country for submission of this patent. It was approved without any objections. A PCT application is now presented for patent rights in e.g. Europe, Russia, USA, Canada, Brasilia, India, Japan, Korea, China, Australia and New Zeeland.